Orthopaedics and Trauma
Volume 23, Issue 4 , Pages 258-265, August 2009

(v) The non-surgical management of musculoskeletal malignancy

Claire Esler BMedSci BMBS MRCP MMedSci FRCR Consultant Clinical Oncologist at the Department of Oncology, Leicester Royal Infirmary, Infirmary Square, Leicester, LE1 5WW, UK

Abstract 

Metastatic bone disease is a common clinical problem that requires a multidisciplinary approach in order to reduce patient suffering and maintain quality of life. Almost all patients with metastatic bone disease will have incurable cancer and this needs to be remembered when considering how to treat these patients. Conversely primary musculoskeletal cancers are rare conditions that need to be managed by specialist centres. Multimodality treatment is needed which may last for many months and may be associated with considerable toxicity. Patients with localised disease can possibly be cured but those with sarcoma remain with a guarded prognosis.

Keywords: bisphosphonates, bone metastases, chemotherapy, Ewing's sarcomas, osteosarcoma, radiotherapy, soft tissue sarcoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1877-1327(09)00087-6

doi:10.1016/j.mporth.2009.06.001

Orthopaedics and Trauma
Volume 23, Issue 4 , Pages 258-265, August 2009